• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4597351)   Today's Articles (14)   Subscriber (49349)
Number Citation Analysis
76
Gardani G, Cerrone R, Biella C, Galbiati G, Proserpio E, Casiraghi M, Arnoffi J, Meregalli M, Trabattoni P, Dapretto E, Giani L, Messina G, Lissoni P. A progress study of 100 cancer patients treated by acupressure for chemotherapy-induced vomiting after failure with the pharmacological approach. Minerva Med 2007;98:665-668. [PMID: 18299681] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/26/2023]
77
Gardani G, Cerrone R, Biella C, Galbiati B, Proserpio E, Casiraghi M, Travisi O, Meregalli M, Trabattoni P, Colombo L, Giani L, Messina G, Arnoffi J, Lissoni P. A case-control study of Panicum Miliaceum in the treatment of cancer chemotherapy-induced alopecia. Minerva Med 2007;98:661-664. [PMID: 18299680] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/26/2023]
78
Lissoni P, Brivio F, Fumagalli L, Messina G, Secreto G, Romelli B, Fumagalli G, Rovelli F, Colciago M, Brera G. Immune and endocrine mechanisms of advanced cancer-related hypercortisolemia. In Vivo 2007;21:647-50. [PMID: 17708360] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/16/2023]
79
Messina G, Lissoni P, Bartolacelli E, Fumagalli L, Brivio F, Colombo E, Gardani GS. Efficacy of IL-2 immunotherapy in metastatic renal cell carcinoma in relation to the psychic profile as evaluated using the Rorschach test. Anticancer Res 2007;27:2985-8. [PMID: 17695482] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/16/2023]
80
Lissoni P. Biochemotherapy with standard chemotherapies plus the pineal hormone melatonin in the treatment of advanced solid neoplasms. ACTA ACUST UNITED AC 2007;55:201-4. [PMID: 17446010 DOI: 10.1016/j.patbio.2006.12.025] [Citation(s) in RCA: 63] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/06/2006] [Accepted: 11/02/2006] [Indexed: 12/15/2022]
81
Lissoni P. Biochemotherapy with immunomodulating pineal hormones other than melatonin: 5-methoxytryptamine as a new oncostatic pineal agent. ACTA ACUST UNITED AC 2007;55:198-200. [PMID: 17451889 DOI: 10.1016/j.patbio.2006.12.008] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/06/2006] [Accepted: 11/02/2006] [Indexed: 11/17/2022]
82
Gardani G, Cerrone R, Biella C, Mancini L, Proserpio E, Casiraghi M, Travisi O, Meregalli M, Trabattoni P, Colombo L, Giani L, Vaghi M, Lissoni P. Effect of acupressure on nausea and vomiting induced by chemotherapy in cancer patients. Minerva Med 2006;97:391-4. [PMID: 17146420] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/12/2023]
83
Lissoni P, Viganò P, Podraska A, Brivio R, Colciago M, Casu M, Manganini V, Giuberti C, Strada G, Gardani G. Chromogranin a Blood Concentrations in Relation to those of Prolactin in Hormone-Refractory Metastatic Prostate Cancer: Possible Existence of Two Independent Mechanisms Responsible for Endocrine Resistance. Int J Biol Markers 2006;21:58-9. [PMID: 16711515 DOI: 10.1177/172460080602100109] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
84
Lissoni P, Fumagalli L, Brivio F, Rovelli F, Messina G, Di Fede G, Colciago M, Brera G. Cancer chemotherapy-induced lymphocytosis: a revolutionary discovery in the medical oncology. J BIOL REG HOMEOS AG 2006;20:29-35. [PMID: 18088552] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 05/25/2023]
85
Lissoni P, Brivio F, Fumagalli L, Di Fede G, Brera G. Enhancement of the efficacy of chemotherapy with oxaliplatin plus 5-fluorouracil by pretreatment with IL-2 subcutaneous immunotherapy in metastatic colorectal cancer patients with lymphocytopenia prior to therapy. In Vivo 2005;19:1077-80. [PMID: 16277025] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/05/2023]
86
Lissoni P, Vigano P, Vaghi M, Frontini L, Giuberti C, Manganini V, Casu M, Brivio F, Niespolo R, Strada G. A phase II study of tamoxifen in hormone-resistant metastatic prostate cancer: possible relation with prolactin secretion. Anticancer Res 2005;25:3597-9. [PMID: 16101186] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/04/2023]
87
Lissoni P, Meregalli S, Bonetto E, Mancuso M, Brivio F, Colciago M, Gardani G. Radiotherapy-induced lymphocytopenia: changes in total lymphocyte count and in lymphocyte subpopulations under pelvic irradiation in gynecologic neoplasms. J BIOL REG HOMEOS AG 2005;19:153-8. [PMID: 16602631] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 05/08/2023]
88
Lissoni P, Messina G, Brivio F, Rovelli F, Di Fede G, Mainini E, Veronese E. Cortisol response to an acute injection of IL-2 in healthy subjects and cancer patients: a first immunoneuroendocrine standardized clinical test to explore the interactions between immune and neuroendocrine systems. J BIOL REG HOMEOS AG 2005;19:141-4. [PMID: 16602629] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 05/08/2023]
89
Ridolfi R, Dall’agata M, Bertetto O, Santo A, Naglieri E, Lopez M, Recchia F, Lissoni P, Porcile G, Fumagalli L, Nanni O. Randomized Italian multicentric trial comparing cisplatinum and gemcitabine with or without low dose interleukin-2 (IL-2) in advanced non-small cell lung cancer (NSCLC). J Clin Oncol 2005. [DOI: 10.1200/jco.2005.23.16_suppl.7139] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open
90
Lissoni P, Bignami A, Frontini L, Manganini V, Dapretto E, Gardani GS, Viganò P, Strada G. Possible involvement of prolactin in endocrine-resistant metastatic prostate cancer. Int J Biol Markers 2005;20:123-5. [PMID: 16011043] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/03/2023]
91
Frontini L, Lissoni P, Vaghi M, Perego MS, Pescia S, Ardizzoia A, Gardani G. Enhancement of the efficacy of weekly low-dose taxotere by the long acting anti-prolactinemic drug cabergoline in pretreated metastatic breast cancer. Anticancer Res 2004;24:4223-6. [PMID: 15736476] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/01/2023]
92
Lissoni P, Vaghi M, Pescia S, Rovelli F, Ardizzola A, Valtulina F, Malugani F, Gardani G, Tancini G. Biological response modifiers of cancer-related neuroendocrine disorders: efficacy of the long-term dopaminergic agonist cabergoline in the treatment of breast cancer-induced hyperprolactinemia. J BIOL REG HOMEOS AG 2004;18:291-4. [PMID: 15786695] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 05/02/2023]
93
Lissoni P, Messina G, Vaghi M, Bartolacelli E, Massarenti LL, Trabattoni P, Meregalli P, Meregalli M, Gavazzeni C, Rovelli F, Tancini G, Gardani GS. A psychoneuroendocrine study of brain dopaminergic sensitivity in locally limited or metastatic cancer patients. In Vivo 2003;17:647-50. [PMID: 14758733] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/28/2023]
94
Messina G, Lissoni P, Bartolacelli E, Tancini G, Villa S, Gardani GS, Brivio F. A psychoncological study of lymphocyte subpopulations in relation to pleasure-related neurobiochemistry and sexual and spiritual profile to Rorschach's test in early or advanced cancer patients. J BIOL REG HOMEOS AG 2003;17:322-6. [PMID: 15065761] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 04/29/2023]
95
Lissoni P, Chilelli M, Villa S, Cerizza L, Tancini G. Five years survival in metastatic non-small cell lung cancer patients treated with chemotherapy alone or chemotherapy and melatonin: a randomized trial. J Pineal Res 2003;35:12-5. [PMID: 12823608 DOI: 10.1034/j.1600-079x.2003.00032.x] [Citation(s) in RCA: 133] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
96
Lissoni P, Ardizzoia A, Cerea G, Acquati M, Simonelli M, Vaghi M, Tancini G, Gardani G. Polyneuroendocrine therapy of advanced breast cancer with LHRH analogue, tamoxifen and the antiprolactinemic drug cabergoline: Phase 2 study. Breast 2003. [DOI: 10.1016/s0960-9776(03)80132-7] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]  Open
97
Cerea G, Vaghi M, Ardizzoia A, Villa S, Bucovec R, Mengo S, Gardani G, Tancini G, Lissoni P. Biomodulation of cancer chemotherapy for metastatic colorectal cancer: a randomized study of weekly low-dose irinotecan alone versus irinotecan plus the oncostatic pineal hormone melatonin in metastatic colorectal cancer patients progressing on 5-fluorouracil-containing combinations. Anticancer Res 2003;23:1951-4. [PMID: 12820485] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/03/2023]
98
Lissoni P, Vaghi M, Villa S, Bodraska A, Cerizza L, Tancini G, Gardani GS. Antiprolactinemic approach in the treatment of metastatic breast cancer: a phase II study of polyneuroendocrine therapy with LHRH-analogue, tamoxifen and the long-acting antiprolactinemic drug cabergoline. Anticancer Res 2003;23:733-6. [PMID: 12680176] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/01/2023]
99
Lissoni P, Mengo S, Bucovec R, Brivio F, Fumagalli L, Tancini G, Gardani GS. Clinical and biological effects of interleukin-2 with or without a concomitant administration of granulocyte-macrophage colony-stimulating factor in metastatic cancer patients. In Vivo 2003;17:73-5. [PMID: 12655794] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/01/2023]
100
Lissoni P, Bordin V, Vaghi M, Fumagalli L, Bordoni A, Mengo S, Bucovec R, Fumagalli E, Malugani F, Ardizzoia A, Giani L, Gardani GS, Tancini G. Ten-year survival results in metastatic renal cell cancer patients treated with monoimmunotherapy with subcutaneous low-dose interleukin-2. Anticancer Res 2002;22:1061-4. [PMID: 12168901] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/26/2023]
PrevPage 4 of 13 123451213Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA